tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ESPR Stock Latest News

Esperion presents new data from CLEAR Outcomes at ACC.24
The FlyEsperion presents new data from CLEAR Outcomes at ACC.24
11d ago
ESPR
Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® (bempedoic acid) Tablets in Diverse Populations Including Women, Hispanics/Latinx and Patients with Obesity
PremiumPress Releases
Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® (bempedoic acid) Tablets in Diverse Populations Including Women, Hispanics/Latinx and Patients with Obesity
11d ago
ESPR
Esperion to Ring Nasdaq Opening Bell Today, April 1, 2024
PremiumPress Releases
Esperion to Ring Nasdaq Opening Bell Today, April 1, 2024
18d ago
ESPR
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
22d ago
AMPE
BLRX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
23d ago
CYTO
ESPR
Esperion to Participate in 23rd Annual Needham Virtual Healthcare Conference
PremiumPress ReleasesEsperion to Participate in 23rd Annual Needham Virtual Healthcare Conference
24d ago
ESPR
Esperion Announces Data from CLEAR Outcomes Sub-Groups as Poster Presentations, Moderated Session & Industry Expert Theatre to be Presented at ACC.24
PremiumPress Releases
Esperion Announces Data from CLEAR Outcomes Sub-Groups as Poster Presentations, Moderated Session & Industry Expert Theatre to be Presented at ACC.24
24d ago
ESPR
Unusually active option classes on open March 25th
PremiumThe Fly
Unusually active option classes on open March 25th
25d ago
ACB
GEO
U.S. FDA Approves Broad New Labels for NEXLETOL® and NEXLIZET® to Prevent Heart Attacks and Cardiovascular Procedures in Both Primary and Secondary Prevention Patients, Regardless of Statin Use
PremiumPress Releases
U.S. FDA Approves Broad New Labels for NEXLETOL® and NEXLIZET® to Prevent Heart Attacks and Cardiovascular Procedures in Both Primary and Secondary Prevention Patients, Regardless of Statin Use
27d ago
ESPR
Esperion: FDA approves broad new labels for NEXLETOL and NEXLIZET
PremiumThe Fly
Esperion: FDA approves broad new labels for NEXLETOL and NEXLIZET
27d ago
ESPR
CHMP Issues Positive Opinions For Both Bempedoic Acid And The Bempedoic Acid / Ezetimibe Fixed-Dose Combination Tablet As Treatments For Hypercholesterolemia And Significantly Reducing Cardiovascular Events
PremiumPress Releases
CHMP Issues Positive Opinions For Both Bempedoic Acid And The Bempedoic Acid / Ezetimibe Fixed-Dose Combination Tablet As Treatments For Hypercholesterolemia And Significantly Reducing Cardiovascular Events
28d ago
ESPR
Esperion reports CHMP issues positive opinions on Nilemdo and Nustendi
PremiumThe Fly
Esperion reports CHMP issues positive opinions on Nilemdo and Nustendi
28d ago
ESPR
Jefferies sees Esperion takeout potential rising after near-term catalysts
PremiumThe FlyJefferies sees Esperion takeout potential rising after near-term catalysts
28d ago
ESPR
Esperion price target lowered to $16 from $22 at H.C. Wainwright
PremiumThe Fly
Esperion price target lowered to $16 from $22 at H.C. Wainwright
2M ago
ESPR
Esperion Reports Fourth Quarter and Full Year 2023 Financial Results
PremiumPress Releases
Esperion Reports Fourth Quarter and Full Year 2023 Financial Results
2M ago
ESPR
Esperion sees 2024 operating expenses $225M-$245M
PremiumThe Fly
Esperion sees 2024 operating expenses $225M-$245M
2M ago
ESPR
Esperion reports Q4 EPS (50c), consensus (48c)
PremiumThe Fly
Esperion reports Q4 EPS (50c), consensus (48c)
2M ago
ESPR
ESPR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
ESPR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
ESPR
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PremiumPress Releases
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2M ago
ESPR
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
2M ago
FSR
ANVS
Esperion to Report Fourth Quarter and Full Year 2023 Financial Results on February 27
PremiumPress Releases
Esperion to Report Fourth Quarter and Full Year 2023 Financial Results on February 27
2M ago
ESPR
RFK, Esperion Therapeutics Announce 2024 Promotional Schedule
PremiumPress Releases
RFK, Esperion Therapeutics Announce 2024 Promotional Schedule
3M ago
ESPR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >